FDA Approves Alpharma's KADIAN(R) New 200 Mg Strength
Fri, 02 Mar 2007 08:00 AM EST
... Alpharma Inc. (NYSE: ALO), a global specialty pharmaceutical company, today announced that it has been notified by United States Food and Drug Administration("FDA") that its pending application for KADIAN(R) 200mg capsule has received approval. The company expects to launch this new dosage strength in the second quarter of 2007. [click link for full article] ...
Related Topics
- Prometrium
- Morphine ER
- Aluminum Hydroxide, Magnesium Carbonate Oral Suspension
- Acetaminophen, Aspirin, Caffeine Oral
- Modafinil
- Acetaminophen and Aspirin and Caffeine powder
- Perindopril
- Aluminum and Magnesium Hydroxide
- Tacrolimus ointment
- Bismuth Subsalicylate
- Pseudoephedrine and Dextromethorphan
- Carvedilol
- Mammography
- Phendimetrazine
- Azithromycin
- Strength Sports
- Ibuprofen
- Carcinogens
- Strength & Weight Training
- Metoprolol ER

Not Signed In -

